KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Equity: 2011-2024

Historic Return on Equity for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to 0.00%.

  • TherapeuticsMD's Return on Equity fell 2.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of 0.00% for FY2024, which is 8.00% up from last year.
  • Latest data reveals that TherapeuticsMD reported Return on Equity of 0.00% as of FY2024, which was up 105.78% from -0.08% recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Return on Equity registered a high of 3.20% during FY2020, and its lowest value of -3.79% during FY2022.
  • Its 3-year average for Return on Equity is -1.29%, with a median of -0.08% in 2023.
  • As far as peak fluctuations go, TherapeuticsMD's Return on Equity skyrocketed by 650bps in 2020, and later tumbled by 465bps in 2022.
  • Over the past 5 years, TherapeuticsMD's Return on Equity (Yearly) stood at 3.20% in 2020, then slumped by 234bps to 0.86% in 2021, then plummeted by 465bps to -3.79% in 2022, then surged by 371bps to -0.08% in 2023, then grew by 8bps to 0.00% in 2024.